ChargePointCHPTRevenue: is the business selling more than it used to?
$411M−1% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $411M in 2025, compounding -4% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $433M, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTNet income: how much of that revenue becomes profit?
$-220MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The company lost $220M in 2025, less than the $277M it lost the year before. The losses are narrowing, but it is still burning shareholder money.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTHow fast is it growing, year by year?
-1.4%revenue growth, FY 2025
→Revenue grew -1% in 2025 against a five-year average of +30%.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTRevenue per share: is your slice growing as fast as the company?
$17.57revenue per share, FY 2025
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year
→Revenue per share reached $17.57 in 2025, compounding -14% a year against -4% for CHPT as a whole. Dilution absorbed about 9.8 points of that growth. Free cash flow per share stands at $-2.86.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTFree cash flow: what is left in real cash after everything?
$-67MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The business consumed $67M of cash in 2025 after investment. Growth is being funded from the balance sheet, not from operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTWhere does each dollar of revenue actually go?
→Of $411M in 2025 sales, nothing survives to the bottom line - the journey ends $220M underwater.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTHow much of every sales dollar ends up as free cash?
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTWhat does staying competitive cost, per dollar of sales?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year
→The biggest claim on each sales dollar is research and development, at 34% of revenue (stock compensation 16%, capital spending 1%). That share has fallen since 2022, so the cost of competing is easing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTMargins: of every $1 of sales, how much survives each cost layer?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year
→Operating margin widened 22 points to -51% since 2022. The bottom line is still negative: costs below the operating line eat what is left.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTWhat does it earn on the money it uses?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year
→Return on capital needs both a profit and an equity base; one of them isn't available here.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTWhat has the market paid for CHPT over time?
0.6xP/S today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 0.6x sales, the market is paying 94% less than CHPT's own 7-year median of 10.0x. Pessimism is priced in - the question is whether it is deserved.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTWhat cash return does the business throw off per dollar of market value?
-25.8%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys -25.8% of annual free cash flow, more than its 6-year median of -6.1% - the cash is cheaper than usual.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTCould it handle its debt if things went wrong?
→Debt of $237M sits against $95M of cash. Earnings don't currently cover the interest bill at all.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTIs the company's own capital growing?
→Shareholders' equity is negative at $-36M: liabilities exceed assets. Usually the mark of heavy buybacks or accumulated losses, and always worth understanding which.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTHow fast is your ownership being diluted - or concentrated?
→The share count grew 8.0% in 2025, averaging 11.5% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTDoes CHPT earn more on its capital than that capital costs?
→CHPT's return on capital is negative at -51.4% in 2025. The capital in the business is not yet earning anything back.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTCHPT has issued or retired shares - did shareholders end up better off?
→CHPT's share count rose +163% from 2019 to 2025 while revenue per share grew +8%. Holders are further ahead than before, though the gain per share is smaller than the growth in the business.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
ChargePointCHPTAre the people running it buying or selling?
→Insiders bought $249,999 and sold $426,328 on the open market, a net sale of $176,329. A further 36 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31